Connecticut Seal

General Assembly

 

Proposed Bill No. 5824

 

January Session, 2005

 

LCO No. 1627

   

Referred to Committee on Public Health

 

Introduced by:

 

REP. WIDLITZ, 98th Dist.

 

AN ACT REQUIRING DISCLOSURE OF CLINICAL DRUG TRIAL RESULTS.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

That the general statutes be amended to require institutional review boards of state hospitals and universities to (1) make available to physicians and the public clinical drug trial results, and (2) register each clinical trial approved by the board with the National Institutes of Health for inclusion in its on-line database of clinical trials.

Statement of Purpose:

To provide physicians and patients access to accurate information about the risks and benefits of drugs being tested in clinical drug trials.